Related Articles
Diagnostic role of fluorodeoxyglucose positron emission tomography‑computed tomography in prostate cancer
FDG PET in suspected recurrent and metastatic prostate cancer
Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer Corrigendum in /10.3892/ol.2015.4039
Diagnostic performance of <sup>18</sup>F‑DCFPyL PET vs. <sup>68</sup>Ga‑PSMA PET/CT in patients with suspected prostate cancer: A systemic review and meta‑analysis
Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report